Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$41.2 - $73.6 $1.16 Million - $2.08 Million
-28,270 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$59.15 - $91.99 $1.67 Million - $2.6 Million
28,270 New
28,270 $1.79 Million
Q4 2020

Feb 12, 2021

SELL
$41.43 - $77.09 $2.24 Million - $4.17 Million
-54,125 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$30.88 - $37.94 $231,847 - $284,853
7,508 Added 16.11%
54,125 $2.05 Million
Q2 2020

Aug 14, 2020

BUY
$18.95 - $35.43 $883,392 - $1.65 Million
46,617 New
46,617 $1.65 Million
Q4 2019

Feb 14, 2020

SELL
$19.24 - $28.41 $4.49 Million - $6.63 Million
-233,482 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$20.03 - $40.08 $259,168 - $518,595
12,939 Added 5.87%
233,482 $5.28 Million
Q2 2019

Aug 14, 2019

BUY
$25.78 - $39.77 $460,044 - $709,695
17,845 Added 8.8%
220,543 $7.94 Million
Q1 2019

May 15, 2019

SELL
$22.09 - $39.21 $94,920 - $168,485
-4,297 Reduced 2.08%
202,698 $6.39 Million
Q4 2018

Feb 14, 2019

BUY
$19.89 - $30.02 $1.67 Million - $2.53 Million
84,195 Added 68.56%
206,995 $5.2 Million
Q3 2018

Nov 14, 2018

BUY
$12.1 - $28.85 $1.49 Million - $3.54 Million
122,800 New
122,800 $3.54 Million
Q2 2018

Aug 14, 2018

SELL
$7.93 - $15.79 $296,367 - $590,119
-37,373 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$5.18 - $7.97 $564,842 - $869,072
-109,043 Reduced 74.47%
37,373 $298,000
Q4 2017

Feb 14, 2018

BUY
$3.98 - $7.37 $582,735 - $1.08 Million
146,416
146,416 $1.08 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Friess Associates LLC Portfolio

Follow Friess Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Friess Associates LLC with notifications on news.